/OMDA
OMDA Stock - Omada Health
Healthcare|Medical - Healthcare Information ServicesNASDAQ
$16.13+0.06%
+$0.01 (+0.06%) • Jan 13
47
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.8
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+55.0%upside
Target: $25.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OMDA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$15.97 – $16.29
TARGET (TP)$25.00
STOP LOSS$14.84
RISK/REWARD1:6.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta6.78
52W High$28.40
52W Low$14.14
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $169.80M | $122.78M | $89.19M |
| Gross Profit | $102.88M | $69.97M | $42.79M |
| Gross Margin | 60.6% | 57.0% | 48.0% |
| Operating Income | $-43,654,000 | $-65,997,000 | $-72,350,000 |
| Net Income | $-47,137,000 | $-67,511,000 | $-72,518,000 |
| Net Margin | -27.8% | -55.0% | -81.3% |
| EPS | $-0.85 | $-1.21 | $-1.30 |
Company Overview
Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
OMDABeat Rate
100%
Last 2 quarters
Avg Surprise
+65.0%
EPS vs Estimate
Beats / Misses
2/0
Last 12 quarters
Latest EPS
$0.02
Q4 2025
EPS Surprise History
Q3 25
+10.0%
$-0.09vs$-0.10
Q4 25
+120.0%
$0.02vs$-0.10
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 5, 2026 | $0.03 | — | — | — |
Q4 2025 | Nov 6, 2025 | $-0.10 | $0.02 | +120.0% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $-0.10 | $-0.09 | +10.0% | ✓ BEAT |
Q2 2025 | May 9, 2025 | — | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about OMDA
What is OMDA's current stock price?
Omada Health (OMDA) is currently trading at $16.13 per share. The stock has moved +0.06% today.
What is the analyst price target for OMDA?
The average analyst price target for OMDA is $25.00, based on 1 analyst.
What sector is Omada Health in?
Omada Health operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.
What is OMDA's market cap?
Omada Health has a market capitalization of $0.93 billion, making it a small-cap company.
Does OMDA pay dividends?
No, Omada Health does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBCRX
BioCryst Pharmaceuticals, Inc.
$6.75
Mkt Cap: $1.4B
MAZE
Maze Therapeutics, Inc.
$41.39
Mkt Cap: $2.0B
OMCL
Omnicell, Inc.
$51.39
Mkt Cap: $2.4B
PGNY
Progyny, Inc.
$25.24
Mkt Cap: $2.2B
PHR
Phreesia, Inc.
$16.58
Mkt Cap: $1.0B
SDGR
Schrödinger, Inc.
$18.31
Mkt Cap: $1.3B
TDOC
Teladoc Health, Inc.
$6.99
Mkt Cap: $1.2B
TXG
10x Genomics, Inc.
$20.52
Mkt Cap: $2.5B
UFPT
UFP Technologies, Inc.
$252.47
Mkt Cap: $1.9B
XERS
Xeris Biopharma Holdings, Inc.
$7.71
Mkt Cap: $1.3B
Explore stocks similar to OMDA for comparison